ClinicalResearch
Excerpt from the article: A preclinical study in the US found that Gilead Sciences’ antiviral drug candidate remdesivir prevented disease progression in rhesus macaques monkeys with Covid-19. “The animals were infected with the novel coronavirus, SARS-CoV-2. Data announced by the National Institutes of Health (NIH) revealed a significant decrease in clinical disease and reduced lung…
Read More
Excerpt from the article: “CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nuritas, a biotechnology company that is revolutionizing the discovery and use of therapeutic peptides through artificial intelligence (AI) and genomics, today announced that it has received a grant from Partnership for Advanced Computing in Europe (PRACE) to identify therapeutic peptides for the treatment of patients with COVID-19. Under the…
Read More
J&J is launching a new video series documenting their process towards developing a vaccine for COVID-19. Excerpt from their announcement: “This new eight-episode educational video series will examine the latest efforts to respond to the COVID-19 pandemic and break down the complex process of developing a vaccine. Each week our host Lisa Ling will talk…
Read More
Excerpt from the press release: “PLYMOUTH MEETING, Pa. and SEOUL, South Korea, April 28, 2020 /PRNewswire/ — INOVIO (NASDAQ:INO) and GeneOne Life Science (KSE:011000) today announced interim data through week 16 from a Phase 1/2a trial of DNA vaccine INO-4700 (also called GLS-5300) for MERS coronavirus (MERS-CoV). Vaccine recipients demonstrated strong antibody and T cell immune…
Read More
Excerpt from the article: “When it comes to viral outbreaks, every day is valuable: stopping a pandemic means getting the right information to the right people at the right time. BlueDot identified the emerging risk of COVID-19 in Hubei province eight days before the World Health Organization.” Click the button below to read the entire…
Read More
Excerpt From the Article: Bay Area-based Vaxart, Inc. has obtained positive pre-clinical results for its COVID-19 vaccine candidates, with several of the vaccine candidates generating immune responses in all tested animals after a single dose. Now, the company plans to push one or more into the clinic. Sean Tucker, Vaxart’s chief scientific officer, said the…
Read More
Excerpt from the article: April 23, 2020 — Chest CT at a radiation dose under 1 mSv can accurately and rapidly assess COVID-19 infection in emergency room patients — particularly those who have had symptoms longer than 48 hours, according to a study published April 21 in Radiology: Cardiothoracic Imaging. The results are good news…
Read More
Excerpt from the article: The Washington University School of Medicine’s Folding@home project will utilise supercomputers at the Science and Technology Facilities Council (STFC) Hartree Centre to better understand protein behaviour in diseases. The project is calling on anyone with a personal computer to help out, as they can lend any unused background capacity to help…
Read More
Excerpt from the article: Regeneron has shared high hopes for its two candidates in the fight against COVID-19 on the first day of the four-day eyeforpharma Philadelphia virtual event. George Yancopolous, President and Chief Scientific Officer at Regeneron, revealed that the company expected to have a good idea of the prospects for Kevzara, one…
Read More
Excerpt from the article: Innovative Solutions Canada has dedicated funding to help combat current and future outbreaks of the novel coronavirus (COVID-19) and other similar threats. Our program will help support the Government of Canada’s fight against COVID-19 by funding R&D and testing prototypes in real-life settings that can help protect Canadians. Click the button…
Read More